GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation

AIMS: To determine whether the Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) integrated risk tool predicts mortality, non-haemorrhagic stroke/systemic embolism, and major bleeding for up to 2 years after new-onset AF and to assess how this risk tool performs compared w...

Descripción completa

Detalles Bibliográficos
Autores principales: Fox, Keith A A, Virdone, Saverio, Pieper, Karen S, Bassand, Jean-Pierre, Camm, A John, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Oto, Ali, Misselwitz, Frank, Piccini, Jonathan P, Dalgaard, Frederik, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888127/
https://www.ncbi.nlm.nih.gov/pubmed/33892489
http://dx.doi.org/10.1093/ehjqcco/qcab028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888127/
https://www.ncbi.nlm.nih.gov/pubmed/33892489
http://dx.doi.org/10.1093/ehjqcco/qcab028

Ejemplares similares